These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 30020995)

  • 1. Twenty-year trend in mortality among hospitalized patients with pneumococcal community-acquired pneumonia.
    Cillóniz C; Liapikou A; Martin-Loeches I; García-Vidal C; Gabarrús A; Ceccato A; Magdaleno D; Mensa J; Marco F; Torres A
    PLoS One; 2018; 13(7):e0200504. PubMed ID: 30020995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pneumococcal and influenza vaccination status of hospitalized adults with community acquired pneumonia and the effects of vaccination on clinical presentation.
    Demirdogen Cetinoglu E; Uzaslan E; Sayıner A; Cilli A; Kılınc O; Sakar Coskun A; Hazar A; Kokturk N; Filiz A; Polatli M;
    Hum Vaccin Immunother; 2017 Sep; 13(9):2072-2077. PubMed ID: 28708954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severity scoring in community-acquired pneumonia caused by Streptococcus pneumoniae: a 5-year experience.
    Ioachimescu OC; Ioachimescu AG; Iannini PB
    Int J Antimicrob Agents; 2004 Nov; 24(5):485-90. PubMed ID: 15519482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age-related differences in management and outcomes in hospitalized healthy and well-functioning bacteremic pneumococcal pneumonia patients: a cohort study.
    Ruiz LA; España PP; Gómez A; Bilbao A; Jaca C; Arámburu A; Capelastegui A; Restrepo MI; Zalacain R
    BMC Geriatr; 2017 Jun; 17(1):130. PubMed ID: 28633626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of hospitalized patients with bacteraemic and non-bacteraemic community-acquired pneumonia caused by Streptococcus pneumoniae.
    Lin SH; Lai CC; Tan CK; Liao WH; Hsueh PR
    Epidemiol Infect; 2011 Sep; 139(9):1307-16. PubMed ID: 20974020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Severity scores for predicting clinically relevant outcomes for immunocompetent adult patients hospitalized with community-acquired pneumococcal pneumonia].
    Saldías F; Díaz O
    Rev Chilena Infectol; 2011 Aug; 28(4):303-9. PubMed ID: 22052393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiological features and prognosis of severe community-acquired pneumococcal pneumonia.
    Georges H; Leroy O; Vandenbussche C; Guery B; Alfandari S; Tronchon L; Beaucaire G
    Intensive Care Med; 1999 Feb; 25(2):198-206. PubMed ID: 10193548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology and outcome of severe pneumococcal pneumonia admitted to intensive care unit: a multicenter study.
    Mongardon N; Max A; Bouglé A; Pène F; Lemiale V; Charpentier J; Cariou A; Chiche JD; Bedos JP; Mira JP
    Crit Care; 2012 Aug; 16(4):R155. PubMed ID: 22894879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Burden of pneumococcal pneumonia requiring ICU admission in France: 1-year prognosis, resources use, and costs.
    Dupuis C; Sabra A; Patrier J; Chaize G; Saighi A; Féger C; Vainchtock A; Gaillat J; Timsit JF
    Crit Care; 2021 Jan; 25(1):24. PubMed ID: 33423691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of 23-valent pneumococcal polysaccharide vaccination in preventing community-acquired pneumonia hospitalization and severe outcomes in the elderly in Spain.
    Domínguez À; Soldevila N; Toledo D; Torner N; Force L; Pérez MJ; Martín V; Rodríguez-Rojas L; Astray J; Egurrola M; Sanz F; Castilla J;
    PLoS One; 2017; 12(2):e0171943. PubMed ID: 28187206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of pneumococcal vaccination in hospitalized adults with community-acquired pneumonia.
    Johnstone J; Marrie TJ; Eurich DT; Majumdar SR
    Arch Intern Med; 2007 Oct; 167(18):1938-43. PubMed ID: 17923592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decrease in the incidence and in hospital mortality of community-acquired pneumonia among children in Spain (2001-2014).
    Jimenez Trujillo I; Lopez de Andres A; Hernandez-Barrera V; Martinez-Huedo MA; de Miguel-Diez J; Jimenez-Garcia R
    Vaccine; 2017 Jun; 35(30):3733-3740. PubMed ID: 28558982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacteraemic and non-bacteraemic/urinary antigen-positive pneumococcal community-acquired pneumonia compared.
    van Mens SP; van Deursen AMM; de Greeff SC; de Melker HE; Schouls LM; van der Ende A; Bonten MJM; Sanders EAM; Vlaminckx BJM
    Eur J Clin Microbiol Infect Dis; 2015 Jan; 34(1):115-122. PubMed ID: 25079513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The burden of hospitalisations for community-acquired pneumonia (CAP) and pneumococcal pneumonia in adults in Spain (2003-2007).
    Gil-Prieto R; García-García L; Alvaro-Meca A; Méndez C; García A; de Miguel AG
    Vaccine; 2011 Jan; 29(3):412-6. PubMed ID: 21111780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hospitalized community-acquired pneumonia due to Streptococcus pneumoniae: Has resistance to antibiotics decreased?
    Vallès X; Marcos A; Pinart M; Piñer R; Marco F; Mensa JM; Torres A
    Chest; 2006 Sep; 130(3):800-6. PubMed ID: 16963678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prognostic factors and mortality in immunocompetent adult patients hospitalized with community-acquired pneumococcal pneumonia].
    Saldías P F; Viviani G P; Pulgar B D; Valenzuela F F; Paredes E S; Díaz P O
    Rev Med Chil; 2009 Dec; 137(12):1545-52. PubMed ID: 20361129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risks of nonsteroidal antiinflammatory drugs in undiagnosed intensive care unit pneumococcal pneumonia: younger and more severely affected patients.
    Messika J; Sztrymf B; Bertrand F; Billard-Pomares T; Barnaud G; Branger C; Dreyfuss D; Ricard JD
    J Crit Care; 2014 Oct; 29(5):733-8. PubMed ID: 24997726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Community-Acquired Pneumococcal Pneumonia in Virologically Suppressed HIV-Infected Adult Patients: A Matched Case-Control Study.
    Cillóniz C; Torres A; Manzardo C; Gabarrús A; Ambrosioni J; Salazar A; García F; Ceccato A; Mensa J; de la Bella Casa JP; Moreno A; Miró JM
    Chest; 2017 Aug; 152(2):295-303. PubMed ID: 28302496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Host-pathogen interactions and prognosis of critically ill immunocompetent patients with pneumococcal pneumonia: the nationwide prospective observational STREPTOGENE study.
    Bedos JP; Varon E; Porcher R; Asfar P; Le Tulzo Y; Megarbane B; Mathonnet A; Dugard A; Veinstein A; Ouchenir K; Siami S; Reignier J; Galbois A; Cousson J; Preau S; Baldesi O; Rigaud JP; Souweine B; Misset B; Jacobs F; Dewavrin F; Mira JP
    Intensive Care Med; 2018 Dec; 44(12):2162-2173. PubMed ID: 30456466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of early, late, and no admission to the intensive care unit for patients hospitalized with community-acquired pneumonia.
    Renaud B; Brun-Buisson C; Santin A; Coma E; Noyez C; Fine MJ; Yealy DM; Labarère J
    Acad Emerg Med; 2012 Mar; 19(3):294-303. PubMed ID: 22435862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.